Member news

Launch of the 2nd call for collective projects Tremplin IA Within the framework of the Enterprise and AI axis of the DigitalWallonia4.ai program, the 2nd call for “collective POC” projects has been launched. Within the framework of the Enterprise and AI axis of the DigitalWallonia4.ai program, the 2nd call for “collective POC”…

News from our members On this page, you will find the latest news from the cluster’s members! • 10/11/20 – Bone Therapeutics, and its collaborators Cerhum, 3D-Side, mSKIL and IREC awarded €3 million in funding under the framework of BioWin, the health cluster of Wallonia, to develop personalized, tissue engineered bone…

The Walloon government approved 2 R&I projects NeuroInsights and FAR join a portfolio of 49 R&I projects NeuroInsights (Call 27) 10 million people worldwide are suffering from Parkinson’s disease and this number is likely to double over the next 10 to 15 years. There is no cure yet. Parkinson’s disease is the…

  Accessia pharma : a dedicated site for your GMP production Accessia Pharma has been designed to allow the healthcare actors to maintain in Wallonia their GMP manufacturing. Accessia Pharma has been designed to allow the healthcare actors to maintain in Wallonia their GMP manufacturing. The major issue for small companies…

DNAlytics is currently involved in several projects related to the fight against COVID-19 Support for the validation of treatments and development of a contagion detection application The members of the cluster keep working  initiatives aimed at ending the crisis. This is the case of DNAlytics, which is currently involved in several…

Mithra Announces Commercial Launch of Myring™ in Germany, the biggest market in Europe Mithra, a company dedicated to Women’s Health announced the commercial launch of Myring™ in Germany, which is the largest European market and the second worldwide in terms of sales volume. Successful launch of Mithra’s hormonal contraceptive ring…

BREAKING NEWS! iTeos Therapeutics closes $125 Million Series B2 Financing iTeos Therapeutics, biotech company in our Walloon ecosystem, raised $125 million to support the clinical development of its two innovative cancer immunotherapy programs. Biotech company iTeos Therapeutics announced Wednesday that it has closed a $125 million Series B2 financing. Proceeds…